Balance Sheet Legend Biotech Corporation

Equities

LEGN

US52490G1022

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 05/06/2026 BST			5-day change	1st Jan Change
32.62 ^USD	-4.62%		+20.10%	+50.05%

06-04	UBS Adjusts Legend Biotech Price Target to $49 From $31, Maintains Buy Rating	MT
06-03	Genscript Associate to Present Data for Lymphoma Drug at European Conference; Shares Surge 11%	MT

7f3d044a1692e0b8c647.M8oYjIAzGFS1zi4ZbWFmPceiyLJPsTDWbqWRXAH81mI.Wf5Jxs5mYBXMrUJeOgQOW7LGmYE59FqRCMf-ZUilmRJnpFXFy3ItMcHjbw

Published financial data: LEGEND BIOTECH CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	89.79M	117M	285M	621M	1.03B
Other Revenues, Total	1.77M	328K	179K	6.26M	-
Total Revenues	91.56M	117M	285M	627M	1.03B
Cost of Goods Sold, Total	-	401M	526M	648M	823M
Gross Profit	91.56M	-284M	-241M	-20.88M	206M
Selling General & Admin Expenses, Total	149M	174M	201M	284M	342M
R&D Expenses	313M	-	-	-	-
Other Operating Expenses	-	-	-	-	1M
Other Operating Expenses, Total	463M	174M	201M	284M	343M
Operating Income	-371M	-458M	-442M	-305M	-136M
Interest Expense, Total	-900K	-10.8M	-21.79M	-21.62M	-21.4M
Interest And Investment Income	971K	8.18M	54.49M	61.2M	40.1M
Net Interest Expenses	71K	-2.61M	32.69M	39.59M	18.7M
Currency Exchange Gains (Loss)	-	-	-	109M	-169M
Other Non Operating Income (Expenses)	-14.04M	14.82M	-111M	3.34M	4M
EBT, Excl. Unusual Items	-385M	-446M	-521M	-154M	-283M
Gain (Loss) On Sale Of Investments	-	603K	663K	-	-
Gain (Loss) On Sale Of Assets	-974K	-481K	-226K	-	-
Asset Writedown	-	-	-	-4.42M	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-386M	-446M	-520M	-158M	-283M
Income Tax Expense	1K	625K	-1.86M	18.89M	14.2M
Earnings From Continuing Operations	-386M	-446M	-518M	-177M	-297M
Net Income to Company	-386M	-446M	-518M	-177M	-297M
Net Income - (IS)	-386M	-446M	-518M	-177M	-297M
Net Income to Common Incl Extra Items	-386M	-446M	-518M	-177M	-297M
Net Income to Common Excl. Extra Items	-386M	-446M	-518M	-177M	-297M
Per Share Items
Net EPS - Basic	-2.74	-2.81	-2.94	-0.97	-1.61
Basic EPS - Continuing Operations	-2.74	-2.81	-2.94	-0.97	-1.61
Basic Weighted Average Shares Outstanding	141M	159M	176M	183M	184M
Net EPS - Diluted	-2.74	-2.81	-2.94	-0.97	-1.62
Diluted EPS - Continuing Operations	-2.74	-2.81	-2.94	-0.97	-1.62
Diluted Weighted Average Shares Outstanding	141M	159M	176M	183M	184M
Normalized Basic EPS	-1.71	-1.75	-1.85	-0.53	-0.96
Normalized Diluted EPS	-1.71	-1.75	-1.85	-0.53	-0.96
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	-360M	-448M	-432M	-294M	-127M
EBITA	-371M	-458M	-442M	-305M	-136M
EBIT	-371M	-458M	-442M	-305M	-136M
EBITDAR	-360M	-447M	-429M	-291M	-123M
Total Revenues (As Reported)	-	117M	285M	627M	1.03B
Effective Tax Rate - (Ratio)	-0	-0.14	0.36	-11.95	-5.02
Current Domestic Taxes	-	224K	511K	997K	4.5M
Current Foreign Taxes	1K	401K	-2.38M	17.9M	9.7M
Total Current Taxes	1K	625K	-1.86M	18.89M	14.2M
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-241M	-279M	-325M	-96.07M	-177M
Interest on Long-Term Debt	142K	527K	1.39M	1.77M	3.5M
Supplemental Operating Expense Items
Selling and Marketing Expenses	103M	93.42M	94.16M	147M	206M
General and Administrative Expenses	46.94M	80.63M	107M	137M	136M
Research And Development Expense From Footnotes	313M	336M	382M	414M	415M
Net Rental Expense, Total	182K	1.13M	2.34M	3.5M	3.7M
Imputed Operating Lease Interest Expense	20.69K	480K	1.33M	1.78M	1.66M
Imputed Operating Lease Depreciation	161K	652K	1.01M	1.72M	2.04M
Stock-Based Comp., Other (Total)	20.16M	34.34M	47.68M	68.94M	64.6M
Total Stock-Based Compensation	20.16M	34.34M	47.68M	68.94M	64.6M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	689M	786M	1.28B	287M	902M
Short Term Investments	193M	54.02M	30.34M	836M	46.7M
Trading Asset Securities, Total	-	186M	663K	-	-
Total Cash And Short Term Investments	882M	1.03B	1.31B	1.12B	949M
Accounts Receivable, Total	50.41M	278K	101M	6.86M	13.1M
Other Receivables	7.04M	45.24M	55.63M	118M	237M
Total Receivables	57.45M	45.52M	157M	125M	250M
Inventory	1.75M	10.35M	19.43M	23.9M	32M
Prepaid Expenses	5.72M	16.33M	12.23M	12.37M	14.6M
Other Current Assets, Total	1.44M	1.27M	357K	70K	1.6M
Total Current Assets	949M	1.1B	1.5B	1.28B	1.25B
Gross Property Plant And Equipment	176M	186M	224M	245M	455M
Accumulated Depreciation	-22.63M	-25.21M	-35M	-43.66M	-53.5M
Net Property Plant And Equipment	153M	161M	189M	201M	402M
Long-term Investments	4.7M	-	4.36M	4.36M	-
Other Intangibles, Total	4.68M	3.41M	4.06M	2.16M	-
Accounts Receivable Long-Term	-	395K	285K	-	-
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	7.32M	67.28M	153M	178M	85.1M
Total Assets	1.12B	1.33B	1.85B	1.67B	1.73B
Liabilities
Accounts Payable, Total	7.04M	32.89M	20.16M	38.59M	83M
Accrued Expenses, Total	106M	153M	105M	64.51M	123M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	319M
Current Portion of Leases	911K	3.56M	3.18M	4.79M	7.4M
Current Income Taxes Payable	515K	9.77M	7.2M	20.67M	19.2M
Unearned Revenue Current, Total	60.95M	451K	53.08M	47.41M	11.3M
Other Current Liabilities	105M	98.38M	27.39M	102M	73.4M
Total Current Liabilities	280M	298M	216M	278M	636M
Long-Term Debt	120M	261M	281M	301M	-
Long-Term Leases	1.59M	20.04M	44.17M	44.61M	87.2M
Unearned Revenue Non Current	244M	7.66M	55.27M	6.15M	-
Other Non Current Liabilities	396K	233K	56K	-	8M
Total Liabilities	647M	587M	597M	630M	732M
Common Stock, Total	31K	33K	36K	37K	100K
Additional Paid In Capital	1.26B	1.66B	2.64B	2.7B	2.75B
Retained Earnings	-817M	-966M	-1.48B	-1.66B	-1.96B
Comprehensive Income and Other	26.69M	53.72M	98.92M	6.27M	210M
Total Common Equity	471M	744M	1.25B	1.04B	1B
Total Equity	471M	744M	1.25B	1.04B	1B
Total Liabilities And Equity	1.12B	1.33B	1.85B	1.67B	1.73B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	154M	165M	182M	184M	185M
ECS Total Common Shares Outstanding	154M	165M	182M	184M	185M
Book Value / Share	3.06	4.51	6.88	5.67	5.42
Tangible Book Value	467M	741M	1.25B	1.04B	1B
Tangible Book Value Per Share	3.02	4.49	6.86	5.65	5.42
Total Debt	123M	285M	329M	351M	414M
Net Debt	-759M	-741M	-980M	-772M	-535M
Debt Equivalent Oper. Leases	1.46M	9.06M	18.7M	28.02M	29.6M
Account Code - Inventory Valuation	6	5	5	5	5
Inventories - Raw Materials, Total	1.75M	6.99M	13.16M	17.45M	24.1M
Inventories - Work In Process, Total	-	690K	2.99M	4.44M	1.1M
Inventories - Finished Goods, Total	-	2.68M	3.29M	2.01M	6.8M
Land - (BS)	2.89M	2.89M	2.89M	2.89M	2.9M
Buildings, Total	59.66M	45.08M	65.54M	65.54M	66M
Machinery, Total	52.31M	46.26M	49.14M	44.92M	57.5M
Full Time Employees	1.07K	1.39K	1.8K	2.6K	2.9K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-386M	-446M	-518M	-177M	-297M
Depreciation & Amortization - CF	12.54M	15.92M	18.53M	21.43M	28.9M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	160K	-
Depreciation & Amortization, Total	12.54M	15.92M	18.53M	21.59M	28.9M
Amortization of Deferred Charges, Total - (CF)	1.38M	2.48M	1.92M	1.77M	-
(Gain) Loss From Sale Of Asset	974K	481K	226K	2K	-
(Gain) Loss on Sale of Investments - (CF)	-	-593K	-663K	-	-
Asset Writedown & Restructuring Costs	-	-	-	4.42M	-
Stock-Based Compensation (CF)	20.16M	34.34M	47.68M	68.94M	64.6M
Provision and Write-off of Bad Debts	-22K	-	-	-	-
Other Operating Activities, Total	11.77M	-47K	129M	-83.85M	196M
Change In Accounts Receivable	24.59M	50.32M	-98.98M	93.75M	-5.7M
Change In Inventories	51K	-8.6M	-12.71M	-17.21M	-4.5M
Change In Accounts Payable	1.8M	25.85M	-12.7M	14.06M	44.4M
Change in Unearned Revenues	-22.23M	6.18M	100M	-49.61M	-40M
Change in Other Net Operating Assets	137M	119M	-46.96M	-20.87M	-87.3M
Cash from Operations	-198M	-201M	-393M	-144M	-100M
Capital Expenditure	-43.9M	-20.93M	-20.08M	-14.1M	-28.6M
Sale of Property, Plant, and Equipment	4K	-	-	-	-
Sale (Purchase) of Intangible assets	-3.21M	-1.35M	-2.64M	-	-
Investment in Marketable and Equity Securities, Total	-148M	-41.36M	205M	-785M	777M
Other Investing Activities, Total	-	-13.45M	-89.07M	-51.88M	-38.8M
Cash from Investing	-195M	-77.09M	92.79M	-851M	710M
Short Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-1.42M	-2.6M	-3.76M	-4.02M	-3.6M
Total Debt Repaid	-1.42M	-2.6M	-3.76M	-4.02M	-3.6M
Issuance of Common Stock	628M	381M	795M	9.72M	3.3M
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	627M	378M	791M	5.7M	-300K
Foreign Exchange Rate Adjustments	34K	-2.51M	682K	-2.08M	6.1M
Net Change in Cash	233M	97.09M	492M	-991M	615M
Supplemental Items
Cash Interest Paid	142K	527K	1.39M	1.77M	3.5M
Cash Income Tax Paid (Refund)	-557K	-3.71M	-308K	1.55M	18.4M
Levered Free Cash Flow	-105M	-203M	-441M	-38.58M	-134M
Unlevered Free Cash Flow	-104M	-196M	-428M	-25.07M	-121M
Change In Net Working Capital	-141M	-59.92M	197M	-87.46M	100M
Net Debt Issued / Repaid	-1.42M	-2.6M	-3.76M	-4.02M	-3.6M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-25.23	-23.37	-17.38	-10.84	-5.01
Return on Total Capital	-52.85	-29.86	-21.19	-12.84	-6.08
Return On Equity %	-102.79	-59.11	-51.94	-15.45	-29.06
Return on Common Equity	-102.79	-59.11	-51.94	-15.45	-29.06
Margin Analysis
Gross Profit Margin %	100	-242.73	-84.62	-3.33	20.03
SG&A Margin	163.25	148.75	70.47	45.32	33.2
EBITDA Margin %	-393.41	-382.79	-151.33	-46.92	-12.35
EBITA Margin %	-405.47	-391.48	-155.09	-48.62	-13.27
EBIT Margin %	-405.47	-391.48	-155.09	-48.65	-13.27
Income From Continuing Operations Margin %	-421.8	-381.48	-181.75	-28.22	-28.85
Net Income Margin %	-421.8	-381.48	-181.75	-28.22	-28.85
Net Avail. For Common Margin %	-421.8	-381.48	-181.75	-28.22	-28.85
Normalized Net Income Margin	-262.96	-238.16	-114.1	-15.32	-17.17
Levered Free Cash Flow Margin	-114.51	-173.2	-154.73	-6.15	-13.02
Unlevered Free Cash Flow Margin	-113.9	-167.44	-149.95	-4	-11.72
Asset Turnover
Asset Turnover	0.1	0.1	0.18	0.36	0.6
Fixed Assets Turnover	0.67	0.78	1.63	3.21	3.41
Receivables Turnover (Average Receivables)	1.43	4.6	5.6	11.47	105.53
Inventory Turnover (Average Inventory)	-	66.27	35.35	29.91	29.44
Short Term Liquidity
Current Ratio	3.39	3.69	6.92	4.62	1.96
Quick Ratio	3.35	3.6	6.77	4.49	1.88
Operating Cash Flow to Current Liabilities	-0.71	-0.68	-1.82	-0.52	-0.16
Days Sales Outstanding (Average Receivables)	254.85	79.43	65.14	31.91	3.46
Days Outstanding Inventory (Average Inventory)	-	5.51	10.33	12.24	12.4
Average Days Payable Outstanding	-	17.79	18.08	19.42	26.71
Cash Conversion Cycle (Average Days)	-	67.15	57.38	24.73	-10.85
Long Term Solvency
Total Debt/Equity	26.1	38.23	26.26	33.69	41.28
Total Debt / Total Capital	20.7	27.66	20.8	25.2	29.22
LT Debt/Equity	25.9	37.75	26.01	33.23	8.7
Long-Term Debt / Total Capital	20.54	27.31	20.6	24.86	6.16
Total Liabilities / Total Assets	57.87	44.08	32.31	37.7	42.2
EBIT / Interest Expense	-412.52	-42.43	-20.29	-14.12	-6.38
EBITDA / Interest Expense	-398.58	-40.95	-19.44	-13.12	-5.03
(EBITDA - Capex) / Interest Expense	-447.37	-42.89	-20.36	-13.77	-6.36
Total Debt / EBITDA	-0.34	-0.64	-0.78	-1.24	-3.84
Net Debt / EBITDA	2.12	1.68	2.31	2.72	4.97
Total Debt / (EBITDA - Capex)	-0.31	-0.61	-0.74	-1.18	-3.04
Net Debt / (EBITDA - Capex)	1.89	1.6	2.21	2.59	3.93
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.27	70	143.7	119.97	64.02
Gross Profit, 1 Yr. Growth %	16.27	16.15	-15.04	-91.34	-1.09K
EBITDA, 1 Yr. Growth %	65.33	16.07	-3.65	-31.8	-56.83
EBITA, 1 Yr. Growth %	64.18	16.25	-3.46	-31.03	-55.26
EBIT, 1 Yr. Growth %	64.18	16.25	-3.46	-31	-55.26
Earnings From Cont. Operations, 1 Yr. Growth %	27.26	10.6	16.11	-65.84	67.68
Net Income, 1 Yr. Growth %	27.26	10.6	16.11	-65.84	67.68
Normalized Net Income, 1 Yr. Growth %	69.24	9.75	16.76	-70.48	83.86
Diluted EPS Before Extra, 1 Yr. Growth %	6.75	-2.05	4.87	-67.11	67.36
Accounts Receivable, 1 Yr. Growth %	-32.77	-99.45	36.39K	-93.24	104.69
Inventory, 1 Yr. Growth %	-2.83	492	87.69	23	33.89
Net Property, Plant and Equip., 1 Yr. Growth %	26.27	14.18	17.71	6.34	99.55
Total Assets, 1 Yr. Growth %	55.11	18.89	38.89	-9.65	3.8
Tangible Book Value, 1 Yr. Growth %	68.17	-2.67	68.35	-16.75	-3.7
Common Equity, 1 Yr. Growth %	68.13	-2.82	68.12	-16.85	-3.7
Cash From Operations, 1 Yr. Growth %	-11	1.42	95.39	-63.38	-30.42
Capital Expenditures, 1 Yr. Growth %	-4.03	-50.41	-4.03	-29.77	102.84
Levered Free Cash Flow, 1 Yr. Growth %	-42.67	64.98	117.7	-91.26	230.44
Unlevered Free Cash Flow, 1 Yr. Growth %	-42.94	60.22	118.25	-94.14	345.91
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	24.49	24.9	103.54	131.53	89.97
Gross Profit, 2 Yr. CAGR %	24.49	34.43	-0.66	-72.88	-7.58
EBITDA, 2 Yr. CAGR %	65.68	41.52	5.75	-18.72	-50.44
EBITA, 2 Yr. CAGR %	65.69	41.16	5.94	-18.18	-49.16
EBIT, 2 Yr. CAGR %	65.69	41.16	5.94	-18.38	-49.16
Earnings From Cont. Operations, 2 Yr. CAGR %	70.42	29.45	13.32	-37.02	-24.33
Net Income, 2 Yr. CAGR %	70.42	29.45	13.32	-37.02	-24.33
Normalized Net Income, 2 Yr. CAGR %	71.59	39.75	13.2	-41.32	-26.29
Diluted EPS Before Extra, 2 Yr. CAGR %	43.6	11.44	1.35	-41.27	-25.81
Accounts Receivable, 2 Yr. CAGR %	29.65	-93.94	41.72	396.57	-64.06
Inventory, 2 Yr. CAGR %	22.95	139.84	233.33	51.94	28.32
Net Property, Plant and Equip., 2 Yr. CAGR %	38.75	19.87	15.93	11.88	45.66
Total Assets, 2 Yr. CAGR %	97.16	35.76	28.5	12.02	-3.16
Tangible Book Value, 2 Yr. CAGR %	94.45	11.6	28	18.39	-10.37
Common Equity, 2 Yr. CAGR %	95.83	11.59	27.82	18.24	-10.51
Cash From Operations, 2 Yr. CAGR %	54.57	-5	40.77	-15.41	-49.53
Capital Expenditures, 2 Yr. CAGR %	6.6	-10.72	-31.01	-17.9	19.28
Levered Free Cash Flow, 2 Yr. CAGR %	10.08	9.19	89.52	-56.37	-48.07
Unlevered Free Cash Flow, 2 Yr. CAGR %	9.87	7.4	87	-64.23	-50.04
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	22.76	23.71	56.08	108.88	106.41
Gross Profit, 3 Yr. CAGR %	22.76	66.26	15.36	-55.96	-10.14
EBITDA, 3 Yr. CAGR %	193.64	51.29	24.5	-8.64	-34.16
EBITA, 3 Yr. CAGR %	190.96	51.2	24.37	-8.18	-33.09
EBIT, 3 Yr. CAGR %	190.96	51.2	24.37	-8.17	-33.21
Earnings From Cont. Operations, 3 Yr. CAGR %	417.67	63.79	24.84	-24.02	-12.72
Net Income, 3 Yr. CAGR %	417.67	63.79	24.84	-24.02	-12.72
Normalized Net Income, 3 Yr. CAGR %	509.07	51.67	31.62	-27.67	-14.13
Diluted EPS Before Extra, 3 Yr. CAGR %	361.81	40.13	9.2	-30.35	-16.74
Accounts Receivable, 3 Yr. CAGR %	24.34	-79	10.28	-48.61	261.2
Inventory, 3 Yr. CAGR %	15.5	107.61	121.02	139.09	45.66
Net Property, Plant and Equip., 3 Yr. CAGR %	68.63	30.11	19.14	12.64	35.68
Total Assets, 3 Yr. CAGR %	37.62	65.69	36.8	14.27	9.21
Tangible Book Value, 3 Yr. CAGR %	278.55	70	27.99	10.9	10.59
Common Equity, 3 Yr. CAGR %	279.1	70.07	27.92	10.75	10.42
Cash From Operations, 3 Yr. CAGR %	-13.6	34.32	20.82	-10.13	-20.75
Capital Expenditures, 3 Yr. CAGR %	27.95	-7.88	-8.54	-30.6	10.97
Levered Free Cash Flow, 3 Yr. CAGR %	-18.88	22.08	37.43	-32.03	-12.88
Unlevered Free Cash Flow, 3 Yr. CAGR %	-19.03	20.76	36.03	-41.04	-14.93
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	37.63	41.94	58.96	68.84
Gross Profit, 5 Yr. CAGR %	-	64.34	37.28	-19.51	5.57
EBITDA, 5 Yr. CAGR %	-	99.76	97.87	17.87	-10.69
EBITA, 5 Yr. CAGR %	-	101.24	96.56	18.14	-9.9
EBIT, 5 Yr. CAGR %	-	101.24	96.56	18.15	-9.9
Earnings From Cont. Operations, 5 Yr. CAGR %	-	116.59	184.43	11.75	2.19
Net Income, 5 Yr. CAGR %	-	116.59	184.43	11.75	2.19
Normalized Net Income, 5 Yr. CAGR %	-	100.28	214.01	3.76	4.36
Diluted EPS Before Extra, 5 Yr. CAGR %	-	130.86	154	-1.04	-6.44
Accounts Receivable, 5 Yr. CAGR %	-	-73.87	31.07	-25.56	-29.57
Inventory, 5 Yr. CAGR %	-	293.32	76.49	83.24	77.82
Net Property, Plant and Equip., 5 Yr. CAGR %	-	122.79	42.78	22.49	29.12
Total Assets, 5 Yr. CAGR %	-	41.02	33.93	41.67	19.15
Tangible Book Value, 5 Yr. CAGR %	-	127.48	170.58	47.09	10.99
Common Equity, 5 Yr. CAGR %	-	127.68	170.45	47.05	10.89
Cash From Operations, 5 Yr. CAGR %	-	142.99	5.03	11.64	-14.79
Capital Expenditures, 5 Yr. CAGR %	-	88.39	-0.85	-12.03	1.73
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	17.57	-19.11	-4.65
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	16.83	-25.77	-6.62